Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Sues Illumina for Patent Infringement

NEW YORK, July 28 (GenomeWeb News) - Affymetrix has filed a lawsuit against Illumina alleging infringement of six Affymetrix patents, Illumina announced last night.


The patents were issued to Affymetrix between 1996 and 2003, and relate to various aspects of arrays, software, and hardware, Illumina said. The company also said in an official statement that it plans to "vigorously defend itself against these allegations."


Illumina markets bead-based technology for large-scale analysis of genetic variation and function. In April, GenomeWeb News' sister publication, BioArray News, reported that Affymetrix would be licensing selected patents specifically related to the use of bead technology in genetic analyses.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.